ReviewPublished 12 October 2026Halogenated and metallic scaffolds as novel efflux pump inhibitors: mechanistic insight in overcoming antimicrobial and cross-domain resistanceManaf AlMatar · Raja Lakhal · Kamaleldin H. Kamaleldin · Arig Ibrahim-HashimFrontiers in Microbiologydoi 10.3389/fmicb.2026.1923157
ReviewPublished 9 October 2026The global emergence of Trichophyton indotineae: epidemiology, resistance, and management challengesDipika Shaw · Adnan Omar · Michelle Singh · Merin Chandanathil · Chandana Bhargavi · Nagaraj Mysore · Dharam Bir · Srinidhi Ramasamy · Prasanna HonnavarFrontiers in Tropical Diseasesdoi 10.3389/fitd.2026.1960706
EditorialPublished 29 June 2026Editorial: Accelerating antibiotic development from natural products: tackling antimicrobial resistance (AMR)Sanjib Bhakta · Cynthia Amaning Danquah · RuAngelie Edrada-Ebel · Simon GibbonsFrontiers in Antibioticsdoi 10.3389/frabi.2026.1898318
Original ResearchPublished 28 May 2026Understanding multi-azole resistance in Aspergillus fumigatus: the impact of non- cyp51A mutation and efflux pump overexpressionPooja Sen · Lokesh Kumar · Jata Shankar · Pooja VijayaraghavanFrontiers in Fungal Biologydoi 10.3389/ffunb.2026.1830942
Original ResearchPublished 29 April 2026Efflux-dominated resistome architecture and phylogeny-resistance decoupling in pharmaceutical effluent-associated Acinetobacter isolatesAswetha Iyer · Riddhi Upadhyay · Periyasamy Ashokkumar · Murugan SevananFrontiers in Bacteriologydoi 10.3389/fbrio.2026.1822309
ReviewPublished 10 February 2026Natural product based approaches to overcome Candida glabrata and emerging AMR threatsBinaya Krushna Sahu · Sudipta Kumar Patra · Mahesh Chandra Sahu · Sujogya Kumar PandaFrontiers in Antibioticsdoi 10.3389/frabi.2026.1767032
Original ResearchPublished 7 January 2026Anti-HER2-targeted therapies: effects on human in vitro blood-brain barrier modelsCarolin J. Curtaz · Rebecca Gebert · Achim Wöckel · Patrick Meybohm · Malgorzata BurekFrontiers in Drug Deliverydoi 10.3389/fddev.2025.1700455
